September - October 2012
sep_oct2012
Respiratory News-September-2012
Respiratory News The FDA has approved a request from Pulmonx, a company based in California and Switzerland, to commence a multi-center clinical trial for the Zephyr Endobronchial Valve. It is a minimally invasive device intended to treat those with emphysema. The therapy involves bronchoscopic placement of one-way valves designed to reduce volume in…
Announcing Our Web Site Design!
Announcing Our Web Site Design! After months and months of hard work by Mr Jim Lee, The Pulmonary Paper web site has an exciting new look with expanded features! Please visit www.pulmonarypaper.org to explore the new changes. Get Daily Pulmonary News! Our web site now has a section that brings you the latest…
Staying Active -September-2012
Staying Active When you have a breathing problem, it is easy to use it as an excuse not to exert yourself. Please don’t get into this rut – the more you are involved in life, the less time you will have to worry about your problems! Take a look at Ruth Ann…
Aging& Disabillty Resourse Center -September-2012
Aging& Disability Resource Center - September-2012 Health and Human Services (HHS) Secretary Kathleen Sebelius announced $12.5 million in awards to Aging and Disability Resource Centers (ADRCs) to support older Americans and people with disabilities stay independent and receive long-term services and supports. These grants, funded by the Affordable Care Act and the Older Americans…
Sharing the Health -September-2012
Sharing the Health Carol Bair is clinical coordinator at National Jewish Health for a nationwide study of N-Acetyl Cysteine (NAC). It’s not being used as a mucolytic agent, but as an antioxidant that will hopefully improve lung function in patients with Idiopathic Pulmonary Fibrosis (IPF). If you live in the Denver, CO area, have IPF…
Ask Mark - September-2012
Ask Mark - September-2012 Mark Mangus not only helps those with lung disease in our country but also answers questions for people from Canada! Our friends at COPD Canada (www.copdcanada.ca) have Mark lend his expertise to help better understand their breathing problems. Shelley writes, I purchased a three-layer cotton, loose fitting mask to deflect the…
FDA Approves New Inhaled Drugs for COPD September-2012
FDA Approves New Inhaled Drugs for COPD Boehringer Ingelheim Pharmaceuticals, Inc. announced that Combivent Respi- mat is now available by prescription in the United States. The propellant-free inhaler uses a slow-moving mist to deliver the same active ingredients as Combivent Inhalation Aerosol. The long-acting drug, called Tudorza Pressair (aclidinium bromide), is a dry…
Fibrosis File September-2012
Fibrosis File The Coalition for Pulmonary Fibrosis (CPF-www.coalition forpf.org) is pleased to an- nounce that instead of just celebrating for one week, September is the first Na- tional Pulmonary Fibrosis Awareness Month! The staff andvolunteers are busy in Washington, DC, encouraging 55 congressmen to support the Pulmonary Fibrosis Research Enhancement Act (H.R. 2505 and S.1350).…
Flu Season 2012–2013-September-2012
2012–2013 Flu Season For those who like details, the World Health Orga- nization recommended that the Northern Hemisphere’s 2012–2013 seasonal influenza vaccine be made from the following three vaccine viruses: an A/California/7/2009 (H1N1)pdm09-like virus; an A/Victoria/361/2011 (H3N2)-like virus; a B/Wisconsin/1/2010-like virus (from the B/ Yamagata lineage of viruses). While the H1N1 virus used to…